Skip to main content
. 2018 Sep 4;16(5):5591–5598. doi: 10.3892/ol.2018.9392

Table III.

Univariate and multivariate analysis of clinicopathological factors for the DFS of 84 patients with breast cancer.

Univariate analysis Multivariate analysis


Characteristic HR (95% CI) P-value HR (95% CI) P-value
Age 0.81 (0.45–1.48) 0.387
Tumor size 1.61 (0.88–2.93) 0.119
Histological grade 2.99 (1.20–7.45) 0.018 4.46 (1.43–13.94) 0.010
Lymph node status 2.85 (1.50–5.38) 0.001 2.13 (1.07–4.56) 0.045
ER status 0.73 (0.36–1.47) 0.376
HER-2 status 1.17 (0.59–2.32) 0.654
Ki-67 3.52 (1.23–10.12) 0.019 4.61 (1.26–16.95) 0.021
POLD1 3.14 (1.67–5.91) <0.001 2.14 (0.99–4.68) 0.048

DFS, disease-free survival; ER, estrogen receptor; HER-2, human epidermal receptor-2; POLD1, polymerase δ catalytic subunit gene.